Social media posts on regenerative medicine increased in the pharma industry in Q1 2023
Notably, Covid-19 was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions ahead of orphan designated drugs and innovation, according to GlobalData.
Of the 50 leading companies in the pharma industry, Pfizer had the most mentions of regenerative medicine in Q1 2023. GlobalData identified 2,048 regenerative medicine-related posts in the industry’s social media activity – 0.13% of all posts – and an increase of 11% in Q1 2023 compared with Q4 2022.
For further understanding of GlobalData’s Regenerative Medicine in Medical – Thematic Research buy the report here.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Social Media Analytics uses machine learning to uncover key insights and track sentiment across millions of social media posts across selected Twitter influencers and Reddit channels.
Source link
#Social #media #posts #regenerative #medicine #increased #pharma #industry
